Special Drug Use-results Surveillance of Tafinlar/Mekinist

RecruitingOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

February 9, 2024

Primary Completion Date

December 31, 2031

Study Completion Date

December 31, 2031

Conditions
BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor
Interventions
DRUG

Tafinlar/Mekinist

There is no treatment allocation. Patients administered Tafinlar/Mekinist by prescription that have started before inclusion of the patient into the study will be enrolled.

Trial Locations (45)

480-1195

RECRUITING

Novartis Investigative Site, Nagakute

453-8511

RECRUITING

Novartis Investigative Site, Nagoya

464 8681

RECRUITING

Novartis Investigative Site, Nagoya

470-0343

RECRUITING

Novartis Investigative Site, Toyota

014-0027

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Daisen

273-8588

RECRUITING

Novartis Investigative Site, Funabashi

277 8577

RECRUITING

Novartis Investigative Site, Kashiwa

812-8582

RECRUITING

Novartis Investigative Site, Fukuoka

830-0011

RECRUITING

Novartis Investigative Site, Kurume

721-8511

RECRUITING

Novartis Investigative Site, Fukuyama

065-0033

RECRUITING

Novartis Investigative Site, Sapporo

660-8511

RECRUITING

Novartis Investigative Site, Amagasaki

650-0011

RECRUITING

Novartis Investigative Site, Kobe

650-0047

RECRUITING

Novartis Investigative Site, Kobe

311-4145

RECRUITING

Novartis Investigative Site, Mito

020 0066

COMPLETED

Novartis Investigative Site, Morioka

890 8520

RECRUITING

Novartis Investigative Site, Kagoshima

252-0375

RECRUITING

Novartis Investigative Site, Sagamihara

236-0004

RECRUITING

Novartis Investigative Site, Yokohama

981-1293

RECRUITING

Novartis Investigative Site, Natori-shi

395-8502

RECRUITING

Novartis Investigative Site, Iida

390-8621

RECRUITING

Novartis Investigative Site, Matsumoto

701-1192

RECRUITING

Novartis Investigative Site, Okayama

598-8577

RECRUITING

Novartis Investigative Site, Izumisano

569-8686

RECRUITING

Novartis Investigative Site, Takatsuki

350 8550

RECRUITING

Novartis Investigative Site, Kawagoe

113 8655

RECRUITING

Novartis Investigative Site, Bunkyo Ku

113-8519

RECRUITING

Novartis Investigative Site, Bunkyo-ku

113-8603

RECRUITING

Novartis Investigative Site, Bunkyo-ku

104 0045

RECRUITING

Novartis Investigative Site, Chuo Ku

105-8471

RECRUITING

Novartis Investigative Site, Minato-ku

108-8639

RECRUITING

Novartis Investigative Site, Minato-ku

157-8535

RECRUITING

Novartis Investigative Site, Setagaya-ku

150-8308

RECRUITING

Novartis Investigative Site, Shibuya City

160-0023

RECRUITING

Novartis Investigative Site, Shinjuku Ku

160 8582

RECRUITING

Novartis Investigative Site, Shinjuku-ku

010-8543

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Akita

781 8555

RECRUITING

Novartis Investigative Site, Kochi

606 8507

RECRUITING

Novartis Investigative Site, Kyoto

534-0021

RECRUITING

Novartis Investigative Site, Osaka

545-8586

RECRUITING

Novartis Investigative Site, Osaka

550-0015

RECRUITING

Novartis Investigative Site, Osaka

330 8777

RECRUITING

Novartis Investigative Site, Saitama

641-8510

RECRUITING

Novartis Investigative Site, Wakayama

990 9585

RECRUITING

Novartis Investigative Site, Yamagata

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY